OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
3.432
+0.042 (1.24%)
Apr 25, 2025, 12:23 PM EDT - Market open
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $98.15 million as of April 25, 2025. Its market cap has increased by 308.97% in one year.
Market Cap
98.15M
Enterprise Value
91.98M
1-Year Change
308.97%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $98.15M, a decrease of -57.08%. That is a compound annual growth rate of -8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 97.00M | 141.90% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |